You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


AbbVie partners with Frontier Medicines on protein degrader

AbbVie has announced a new partnership with precision medicine company Frontier Medicines to discover and develop small molecules therapeutics for difficult-to-treat protein targets.